Emergence of blaKPC carbapenemase genes in Australia

International Journal of Antimicrobial Agents

Volumn 45, Issue 2, 2015, Pages 130-136

  Partridge, Sally R ^a,b,c   Ginn, Andrew N ^a,b,c   Wiklendt, Agnieszka M ^a,d   Ellem, Justin ^d   Wong, Jenny S J ^e   Ingram, Paul ^f,g   Guy, Stephen ^h   Garner, Sarah ⁱ   Iredell, Jonathan R ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c University of Sydney   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

^e Dorevitch Pathology Department of Microbiology   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h Department of Infectious Diseases Western Health ^*  (Australia)

ⁱ Dorevitch Pathology   (Australia)

Author keywords

blaKPC; K. pneumoniae; ompk; Plasmid; ST258

Indexed keywords

CARBAPENEMASE; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLAKPC 2 GENE; BLAKPC GENE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE; GENE AMPLIFICATION; GENE INSERTION; GENE SEQUENCE; GENETIC ASSOCIATION; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; OMPK35 GENE; OMPK36 GENE; PULSED FIELD GEL ELECTROPHORESIS; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; MULTIPLEX POLYMERASE CHAIN REACTION; PLASMID;

BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; HUMANS; KLEBSIELLA PNEUMONIAE; MULTIPLEX POLYMERASE CHAIN REACTION; NEW SOUTH WALES; PLASMIDS;

EID: 84921456529     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.10.006     Document Type: Article

References (32)

1. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791-8.
2. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011;35:736-55.
3. Warburg G, Hidalgo-Grass C, Partridge SR, Tolmasky M, Temper V, Moses A, et al. A carbapenem-resistant Klebsiella pneumoniae epidemic clone in Jerusalem: sequence type 512 carrying a plasmid encoding aac(6′)-Ib. J Antimicrob Chemother 2012;67:898-901.
4. KPC gene expression. Antimicrob Agents Chemother 2012;56:4753-9.
5. García-Fernández A, Villa L, Carta C, Venditti C, Giordano A, Venditti M, et al. Klebsiella pneumoniae ST258 producing KPC-3 identified in Italy carries novel plasmids and OmpK36/OmpK35 porin variants. Antimicrob Agents Chemother 2012;56:2143-5.
6. Leavitt A, Chmelnitsky I, Carmeli Y, Navon-Venezia S. Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258. Antimicrob Agents Chemother 2010;54:4493-6.
7. Kassis-Chikhani N, Frangeul L, Drieux L, Sengelin C, Jarlier V, Brisse S, et al. Complete nucleotide sequence of the first KPC-2- and SHV-12-encoding IncX plasmid pKpS90 from Klebsiella pneumoniae. Antimicrob Agents Chemother 2012;57:618-20.
8. KPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob Agents Chemother 2009;53:1998-2004.
9. Tenover FC, Kalsi RK, Williams PP, Carey RB, Stocker S, Lonsway D, et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 2006;12:1209-13.
10. Martínez-Martínez L. Extended-spectrum β-lactamases and the permeability barrier. Clin Microbiol Infect 2008;14:82-9.
11. Kitchel B, Rasheed JK, Endimiani A, Hujer AM, Anderson KF, Bonomo RA, et al. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2010;54:4201-7.
12. Coatsworth NR, Huntington PG, Hardiman RP, Hudson BJ, Fernandes CJ. A case of carbapenemase-producing Klebsiella pneumoniae in Australia. Pathology 2012;44:42-4.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011.
14. Ginn AN, Zong Z, Wiklendt AM, Thomas LC, Merlino J, Gottlieb T, et al. Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae. Int J Antimicrob Agents 2013;42:19-26.
15. Nüesch-Inderbinen MT, Hächler H, Kayser FH. Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis 1996;15:398-402.
16. CTX-M-15 on conjugative IncF plasmids from Escherichia coli. Antimicrob Agents Chemother 2011;55:4971-8.
17. CTX-M within an Australian extended-spectrum β-lactamase gene pool. Antimicrob Agents Chemother 2008;52:4198-202.
18. Partridge SR. Analysis of antibiotic resistance regions in Gram-negative bacteria. FEMS Microbiol Rev 2011;35:820-55.
19. Kassis-Chikhani N, Decre D, Ichai P, Sengelin C, Geneste D, Mihaila L, et al. Outbreak of Klebsiella pneumoniae producing KPC-2 and SHV-12 in a French hospital. J Antimicrob Chemother 2010;65:1539-40.
20. Wiener-Well Y, Rudensky B, Yinnon AM, Kopuit P, Schlesinger Y, Broide E, et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J Hosp Infect 2010;74:344-9.
21. KPC-negative sequence type 258 Klebsiella pneumoniae clone. J Clin Microbiol 2012;50:3180-5.
22. Chmelnitsky I, Shklyar M, Hermesh O, Navon-Venezia S, Edgar R, Carmeli Y. Unique genes identi.ed in the epidemic extremely drug-resistant KPC-producing Klebsiella pneumoniae sequence type 258. J Antimicrob Chemother 2013;68:74-83.
23. SHV mobilization events from the Klebsiella pneumoniae chromosome. J Antimicrob Chemother 2004;54:69-75.
24. Tóth A, Damjanova I, Puskás E, Jánvári L, Farkas M, Dobák A, et al. Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary. Eur J Clin Microbiol Infect Dis 2010;29:765-9.
25. Clancy CJ, Chen L, Hong JH, Cheng S, Hao B, Shields RK, et al. Mutations of the ompK36 porin gene and promoter impact responses of ST258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin. Antimicrob Agents Chemother 2013;57:5258-65.
26. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. European emergence of cipro.oxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008;46:2605-12.
27. Dutzler R, Rummel G, Albertí S, Hernández-Allés S, Phale P, Rosenbusch J, et al. Crystal structure and functional characterization of OmpK36, the osmoporin of Klebsiella pneumoniae. Structure 1999;7:425-34.
28. Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, et al. Comparative review of the carbapenems. Drugs 2007;67:1027-52.
29. García-Fernández A, Miriagou V, Papagiannitsis CC, Giordano A, Venditti M, Mancini C, et al. An ertapenem-resistant extended-spectrum-β-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob Agents Chemother 2010;54:4178-84.
30. Wright MS, Perez F, Brinkac L, Jacobs MR, Kaye K, Cober E, et al. Population structure of KPC-producing Klebsiella pneumoniae isolates from midwestern U.S. hospitals. Antimicrob Agents Chemother 2014;58:4961-5.
31. KPC gene. Antimicrob Agents Chemother 2008;52:1257-63.
32. Landman D, Bratu S, Quale J. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 2009;58:1303-8.